{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:02:59Z","timestamp":1787497379580,"version":"build-2736575974"},"reference-count":15,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T00:00:00Z","timestamp":1518134400000},"content-version":"vor","delay-in-days":1653,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.jchf.2013.05.005","type":"journal-article","created":{"date-parts":[[2013,8,5]],"date-time":"2013-08-05T18:30:37Z","timestamp":1375727437000},"page":"315-317","source":"Crossref","is-referenced-by-count":8,"title":["PRAISE (Prospective Randomized Amlodipine Survival Evaluation) and\u00a0Criticism \u2217"],"prefix":"10.1016","volume":"1","author":[{"given":"Marc A.","family":"Pfeffer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hicham","family":"Skali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2013.05.005_bib1","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1161\/01.CIR.92.9.2764","article-title":"Guidelines for the evaluation and management of heart failure: report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure)","volume":"92","author":"Williams","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2013.05.005_bib2","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1056\/NEJM199610103351504","article-title":"Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group","volume":"335","author":"Packer","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2013.05.005_bib3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1001\/jama.1991.03470010097038","article-title":"Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials","volume":"266","author":"Yusuf","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2013.05.005_bib4","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1161\/CIRCULATIONAHA.108.836601","article-title":"On looking at subgroups","volume":"119","author":"Wittes","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2013.05.005_bib5","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMsr077003","article-title":"Statistics in medicine\u2014reporting of subgroup analyses in clinical trials","volume":"357","author":"Wang","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2013.05.005_bib6","first-page":"308","article-title":"Effect of amlodipine on the survival of patients with severe chronic heart failure due to a nonischemic cardiomyopathy: results of the PRAISE-2 study (Prospective Randomized Amlodipine Survival Evaluation 2) Study","volume":"1","author":"Packer","year":"2013","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jchf.2013.05.005_bib7","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0140-6736(97)01187-2","article-title":"Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)","volume":"349","author":"Pitt","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2013.05.005_bib8","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(00)02213-3","article-title":"Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial\u2014the Losartan Heart Failure Survival Study ELITE II","volume":"355","author":"Pitt","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2013.05.005_bib9","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1056\/NEJMe068061","article-title":"The charisma of subgroups and the subgroups of CHARISMA","volume":"354","author":"Pfeffer","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2013.05.005_bib10","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1056\/NEJM198808183190701","article-title":"The effect of diltiazem on mortality and reinfarction after myocardial infarction","volume":"319","year":"1988","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2013.05.005_bib11","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2005.08.022","volume":"46","author":"Hunt","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2013.05.005_bib12","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMsa065779","article-title":"Selective publication of antidepressant trials and its influence on apparent efficacy","volume":"358","author":"Turner","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2013.05.005_bib13","first-page":"112","article-title":"Better late than never","volume":"1","author":"Califf","year":"2013","journal-title":"J Am Coll Cardiol HF"},{"key":"10.1016\/j.jchf.2013.05.005_bib14","doi-asserted-by":"crossref","first-page":"477","DOI":"10.7326\/0003-4819-141-6-200409210-00109","article-title":"Clinical trial registration: a statement from the International Committee of Medical Journal Editors","volume":"141","author":"De Angelis","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jchf.2013.05.005_bib15","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1371\/journal.pmed.0050217","article-title":"Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation","volume":"5","author":"Rising","year":"2008","journal-title":"PLoS Med"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177913001923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177913001923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T00:50:34Z","timestamp":1539478234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177913001923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S2213177913001923"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2013.05.005","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}